Status:
COMPLETED
Enhanced Triage for COVID-19
Lead Sponsor:
University Health Network, Toronto
Conditions:
COVID-19
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
This study is to evaluate of the accuracy of biomarkers (i.e. circulating endothelial and immune activation markers) that indicate progression to severe disease in patients with suspected COVID-19 in ...
Eligibility Criteria
Inclusion
- Patients presenting with clinical suspicion of COVID-19 infection, as per UHN case definition at the time of presentation
- Age \>18 years
- Ability to provide verbal informed consent
Exclusion
- Patients who are not suspected of COVID-19 infection, as per UHN definition at the time of presentation
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 23 2023
Estimated Enrollment :
806 Patients enrolled
Trial Details
Trial ID
NCT04750369
Start Date
April 1 2020
End Date
March 23 2023
Last Update
December 28 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pontifícia Universidade Católica do Rio Grande do Sul
Porto Alegre, Brazil
2
University Health Network
Toronto, Ontario, Canada, M5G 2C4
3
Cittá della Salute e della Scienza di Torino Hospital-Molinette Site
Turin, Italy